Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Sexual dysfunction is a reality for many women, but the subject remains taboo. A large percentage of women remain untreated, a problem that is exacerbated by the shortage of treatment options for ...

Steve Jones was left with an unwanted side effect after undergoing surgery for prostate cancer: erectile dysfunction that ...

Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Ryan Allen, an assistant professor of physiology and cell biology at UAMS, will share a current project from his lab dedicated to developing a drug-responsive mouse model of atherosclerosis, a disease ...

FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...

Hårklinikken’s clinically backed formula is helping women regrow hair through a multifactorial approach leading to long term ...

When the heart’s muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...